Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Extending Gains Ahead of Tuesday Close

08/03/2021 | 04:03pm EDT


ę MT Newswires 2021
All news about GUARDANT HEALTH, INC.
09/15GUARDANT HEALTH : Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360« Liquid..
BU
09/14INSIDER SELL : Guardant Health
MT
09/07GUARDANT HEALTH : New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Adva..
AQ
09/02Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
GL
08/23CONNECT BIOPHARMA : Names General Counsel & Chief Compliance Officer
MT
08/09GUARDANT HEALTH : Canaccord Genuity Adjusts Guardant Health's Price Target to $180 From $1..
MT
08/06GUARDANT HEALTH : to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
BU
08/05GUARDANT HEALTH : Q2 Earnings Snapshot
AQ
08/05GUARDANT HEALTH : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/05Guardant Health, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 20..
CI
More news
Analyst Recommendations on GUARDANT HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 368 M - -
Net income 2021 -399 M - -
Net cash 2021 101 M - -
P/E ratio 2021 -33,4x
Yield 2021 -
Capitalization 13 297 M 13 297 M -
EV / Sales 2021 35,8x
EV / Sales 2022 26,6x
Nbr of Employees 864
Free-Float 95,6%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | GH | US40131M1099 | MarketScreener
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 131,27 $
Average target price 161,31 $
Spread / Average Target 22,9%
EPS Revisions
Managers and Directors
Helmy Eltoukhy Chairman & Co-Chief Executive Officer
AmirAli H. Talasaz President, Co-Chief Executive Officer & Director
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors